Innovative Antimicrobial Strategies for Future Therapeutics
A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Bacterial Pathogens".
Deadline for manuscript submissions: 10 June 2027 | Viewed by 58
Editors
Interests: antimicrobial resistance (AMR); antimicrobial peptides (AMPs); peptidomimetics; biofilms; periprosthetic joint infections (PJI); infectious diseases; phage therapy; pharmaceutical microbiology; drug discovery; translational microbiology; one health; food safety microbiology; veterinary microbiology; clinical microbiology; molecular diagnostics; biomaterials and medical device infections; drug policy
2. Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada
Interests: periprosthetic joint infections (PJI); phage therapy; infectious diseases; clinical microbiology; antimicrobial resistance (AMR); biofilm-associated infections; orthopedic infections; translational medicine; molecular diagnostics; culture-negative infections; precision infectious disease diagnostics; clinical research; synovial fluid biomarkers; proteomics; biofilm eradication strategies; emerging infectious diseases; translational infectious disease research; personalized infection management; diagnostic microbiology; multidrug-resistant pathogens; medical device-associated infections
Special Issue Information
Dear Colleagues,
Antimicrobial resistance (AMR) is no longer a looming threat—it is one of the most urgent crises facing modern medicine, quietly undermining decades of clinical progress and making routine medical procedures risky. The rapid rise in multidrug-resistant (MDR), extensively drug-resistant (XDR), and even pandrug-resistant (PDR) pathogens, coupled with a stagnant antibiotic pipeline, leaves us with a clear directive: we need innovative, alternative antimicrobial strategies, and we need them now.
Compounding this crisis are complex microbial behaviors such as biofilm formation on living tissues and medical devices, alongside fastidious or culture-negative infections that slip through standard diagnostic nets and evade traditional treatments. To meet these challenges head-on, we would like to invite you to contribute a paper to this Special Issue in Pathogens, “Innovative Antimicrobial Strategies for Future Therapeutics.”
Our goal is to highlight the discovery, development, and translational application of next-generation tools designed to shatter conventional resistance mechanisms. We welcome original research articles and reviews focused on next-generation antimicrobial strategies, including antimicrobial peptides (AMPs), lipopeptides, phage therapy, synergistic therapies, anti-biofilm and anti-virulence approaches, molecular diagnostics, smart biomaterials, nanotechnology, and targeted drug-delivery systems. Particular interest will be given to studies addressing difficult-to-treat infections such as periprosthetic joint infections (PJI), orthopedic and device-associated infections, biofilm-mediated diseases and broader infectious challenges viewed through a One Health lens.
While excellent research exists on isolated resistance mechanisms, this Special Issue aims to bridge the gap between benchside molecular discovery and bedside clinical application. By uniting brilliant minds across microbiology, infectious diseases, peptide chemistry, biomaterials, and pharmaceutical sciences, we hope to build a forward-looking roadmap for tackling refractory pathogens.
We invite you to submit original research articles, reviews, short communications, perspectives, or case reports. Let us work together to shape the future of infectious disease therapeutics. We look forward to receiving your contributions.
Best regards,
Dr. Md Ramim Tanver Rahman
Dr. Marisa Azad
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance (AMR)
- multidrug-resistant (MDR) pathogens
- extensively drug-resistant (XDR) pathogens
- pandrug-resistant (PDR) pathogens
- antimicrobial peptides (AMPs)
- lipopeptides
- phage therapy
- anti-biofilm strategies
- anti-virulence therapies
- biofilms
- periprosthetic joint infections (PJI)
- orthopedic infections
- device-associated infections
- infectious diseases
- translational medicine
- molecular diagnostics
- smart biomaterials
- nanotechnology
- drug-delivery systems
- precision therapeutics
- pharmaceutical sciences
- clinical microbiology
- microbial persistence
- one health
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
